HEPATITIS B VIRUS (HBV) NUCLEAR NUCLEIC ACID - ANVISA Registration 80102513323
Access comprehensive regulatory information for HEPATITIS B VIRUS (HBV) NUCLEAR NUCLEIC ACID in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80102513323 and manufactured by manufacturer not specified. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until Dec 02, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 4 companies making the same product including ALTONA DIAGNOSTICS GMBH, FUJIREBIO EUROPE N.V., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80102513323
25351628281202313
04718143000194
Company Information
Dates and Status
Dec 02, 2024
02/12/2034
09/18/2025 19:00:01
ÁCIDO NUCLÉICO NUCLEAR DE VÍRUS DE HEPATITE B (HBV)
AltoStar® HBV PCR Kit 1.5
ALTONA DIAGNOSTICS GMBH
81752180020
Jul 10, 2023
ÁCIDO NUCLÉICO NUCLEAR DE VÍRUS DE HEPATITE B (HBV)
AltoStar® HBV PCR Kit 1.5
Not specified
81752180020
Jul 10, 2023
ÁCIDO NUCLÉICO NUCLEAR DE VÍRUS DE HEPATITE B (HBV)
INNO-LIPA HBV GENOTYPING
FUJIREBIO EUROPE N.V.
80102512520
Aug 03, 2020
ÁCIDO NUCLÉICO NUCLEAR DE VÍRUS DE HEPATITE B (HBV)
INNO-LIPA HBV GENOTYPING
Not specified
80102512520
Aug 03, 2020
ÁCIDO NUCLÉICO NUCLEAR DE VÍRUS DE HEPATITE B (HBV)
Cobas HBV
ROCHE DIAGNOSTICS GMBH.
10287411154
Aug 01, 2016

